Trim to Underweight at 60-70% benchmark weight in A&D sleeve; keep stop at 202 (50 SMA); hold 25% reserve for re-entry at 220 with 10 EMA and MACD confirmation; exit fully on close below 210.85 with volume above 5 million shares

• 200 SMA at 189.95 is major institutional reversion anchor with three successful tests in eight months
• RTX defensive characteristics: beta 0.29, government-contracted backlog, near-zero consumer cycle sensitivity
• Q2 2026 audited results: revenue up 14.5%, net income up 29%, EPS up 28.7%, FCF $2.82 billion quarterly, net debt down $8 billion YoY
• ATR of 5.00 supports $10 stop; 10.5% drawdown to 200 SMA from current levels
• 30-year yield at 2007 highs; recession probability at 8%
• Downside risk is defined range: 4.8% to first support (50 SMA), 10.5% to second support (200 SMA at 189.95), then 52-week low around 150
• Re-entry requires price confirmation plus 10 EMA turned up and MACD histogram flipped positive
• Hard cap: close below 210.85 on volume above 5 million shares triggers full exit - this Bollinger lower band break on heavy volume is the actual distribution signal
• RTX forward P/E has averaged 20-25x during stable macro periods; 27x to 22x compression is recessionary tail case, not central scenario

→ vs aggressive: 200 SMA at 189.95 was incorrectly dismissed as 'lagging' - it has defined every major floor in RTX for two years, catching the pullback to 170 in April-May 2026 and holding at 192 in late July. The 200 SMA is the long-term institutional reversion anchor, not noise.

→ vs aggressive: The 27x compression to 22x scenario assumes a 5-turn multiple compression during rising EPS (7.86) - this is a recessionary tail case, not the central case. Recession probability is only 8%, and you're pricing a 12% probability event as if it were baseline.

→ vs aggressive: The April-May 2026 comparison is one data point. The same technical signals (10 EMA rollovers, MACD negatives, volume distributions) appeared in late February 2026, and RTX ripped from 192 to 225 after a shallow pullback. Aggressive analyst anchored on the outcome that confirmed the thesis and ignored the outcome that didn't - narrative bias, not methodology.

→ vs aggressive: Framing downside as 'open-ended' is reckless. Actual risk structure is defined: 4.8% to first support (50 SMA), 10.5% to second support (200 SMA at 189.95), then 52-week low around 150. This is a bounded range, not tail risk.

→ vs aggressive: Institutional crowding with audited Q2 2026 fundamentals (revenue up 14.5%, net income up 29%, EPS up 28.7%, FCF $2.82 billion, net debt down $8B) is not distribution - it's justified positioning. Contrarian framing of real earnings beats and contracted backlog is contrarianism without purpose.

→ vs neutral: The Neutral HOLD position has no defined invalidation levels - if the 50 SMA breaks on volume, there is no new thesis. The report has none of the hard triggers that make a HOLD a risk-managed stance rather than a research note. 'Wait for confirmation' becomes indefensible if trailing the S&P 300 widens from 8.4% to 12%.

→ vs neutral: Punting on the decision after writing a structurally bullish long-term report is not analysis - it's a vibe. The Neutral position is only valid with hard invalidation levels tied to it, which the report lacks entirely.

SELL (trim to approximately 75% of benchmark weight)

• Technical deterioration is real: 10 EMA rollover, MACD bearish cross, price hugging Bollinger lower band after a 4.9 million share down day
• 200 SMA at 189.95 has caught every meaningful RTX drawdown for two years (April-May 170 low, late July 192 test) and should not be dismissed
• Macro overlay creates credible compression risk: 30-year at 2007 highs, Fed priced at 86% probability of zero cuts
• Defensive characteristics (0.29 beta, $22.9 billion Tomahawk contract, deleveraging trajectory) warrant keeping a meaningful position rather than full exit
• Agrees with trim direction but disagrees with Aggressive's 27x to 22x to 173 scenario as central case—it requires recession which macro data does not price
• Stop at 202 stays (aligned with 50 SMA, roughly two ATR below current, structural level)
• Re-entry at 220 requires price to clear level on volume above 4.5 million shares only—does NOT require 10 EMA turning up or MACD histogram positive
• Hard invalidation added: if RTX closes below 210.85 on volume above 5 million shares, exit remaining position entirely
• Rotate approximately 30 percent of trimmed proceeds into shorter-duration industrial names, defense names with less multiple compression risk, or cash for opportunistic re-deployment at 195-200

→ vs aggressive: 200 SMA dismissal is wrong—the line at 189.95 has defined the floor twice in eight months and cannot be discarded without structural evidence that RTX's institutional bid has changed

→ vs aggressive: 27x to 22x to 173 scenario is a tail case presented as base case—five-turn compression on accelerating earnings, multi-year backlog, deleveraging momentum, and 0.29 beta requires recession which has only 8 percent probability

→ vs aggressive: Institutional crowding narrative fails when fundamentals are solid—Q2 revenue up 14.5 percent, EPS up 28.7 percent, FCF of 2.82 billion, net debt down 8 billion year-over-year

→ vs conservative: Re-entry condition too restrictive—waiting for both 10 EMA rolling up AND MACD histogram flipping positive means missing two to three dollars of the move, forfeiting asymmetry

→ vs conservative: Defensive characteristics moderated the April-May drawdown but did not prevent it—RTX sold 12 percent during that period

→ vs conservative: Structural dishonesty in framing—recommending trim to 60-70 percent of benchmark weight is only 10-15 percent different from trader, making this a sizing debate dressed as thesis disagreement